Hebert, A. A., Flohr, C., Hong, H. C., Irvine, A. D., Pierce, E., Elmaraghy, H., . . . Weidinger, S. Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials. Taylor & Francis Group.
Chicago Style (17th ed.) CitationHebert, Adelaide A., et al. Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-severe Atopic Dermatitis: 16-week Results from Three Randomized Phase 3 Clinical Trials. Taylor & Francis Group.
MLA (9th ed.) CitationHebert, Adelaide A., et al. Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-severe Atopic Dermatitis: 16-week Results from Three Randomized Phase 3 Clinical Trials. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.